Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-almd-2_08-cv-00438/USCOURTS-almd-2_08-cv-00438-1/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

IN THE DISTRICT COURT OF THE UNITED STATES FOR THE

MIDDLE DISTRICT OF ALABAMA, NORTHERN DIVISION

CHARLES COLLINS, )

)

 Plaintiff, )

) CIVIL ACTION NO.

 v. ) 2:08cv438-MHT

) (WO)

NOVARTIS PHARMACEUTICALS )

CORPORATION, )

)

 Defendant. )

OPINION

Plaintiff Charles Collins filed this lawsuit 

asserting a claim of breach of the implied warranty of 

merchantability against defendant Novartis 

Pharmaceuticals Corporation for its product Aredia©, 

which he contends caused him to suffer 

bisphosphonate-related osteonecrosis of the jaw. After 

remand from the MDL court, this lawsuit is now before 

this court on the recommendation of the United States 

Magistrate Judge that Novartis’s motion for summary 

judgment should be granted. Also before the court are 

Collins’s objections to the recommendation. After an 

Case 2:08-cv-00438-MHT-PWG Document 43 Filed 05/11/15 Page 1 of 2
independent and de novo review of the record, the court 

concludes that Collins’s objections should be overruled 

and the magistrate judge’s recommendation adopted. 

However, as the resolution of the 

statute-of-limitations argument is unnecessary, the 

court adopts only the part of the recommendation 

finding that Collins cannot establish an 

implied-warranty-of-merchantability claim under the 

facts of this case.

An appropriate judgment will be entered.

DONE, this the 11th day of May, 2015.

 /s/ Myron H. Thompson 

UNITED STATES DISTRICT JUDGE

Case 2:08-cv-00438-MHT-PWG Document 43 Filed 05/11/15 Page 2 of 2